Company Description
WORK Medical Technology Group LTD, through its subsidiaries, manufactures and sells medical consumables in the People’s Republic of China.
The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters.
It also exports its products to Asia, Africa, Europe, North America, South America, and Oceania. The company was founded in 2002 and is based in Hangzhou, China.
| Country | China |
| Founded | 2002 |
| IPO Date | Aug 23, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 229 |
| CEO | Shuang Wu |
Contact Details
Address: No. 2 Tonghuinan Road, 23rd Floor Hangzhou China | |
| Phone | 86 571 8261 3568 |
Stock Details
| Ticker Symbol | WOK |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001929783 |
| CUSIP Number | G9767H109 |
| ISIN Number | KYG9767H1092 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Shuang Wu | Chairman and Chief Executive Officer |
| Ningfang Liang | Chief Financial Officer |
| Baiming Yu | Chief Operating Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 20, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Feb 7, 2025 | 6-K | Report of foreign issuer |
| Jan 31, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Jan 16, 2025 | 6-K | Report of foreign issuer |
| Jan 10, 2025 | 6-K | Report of foreign issuer |
| Dec 23, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Dec 2, 2024 | DRS | [Cover] Draft Registration Statement |
| Oct 23, 2024 | 6-K | Report of foreign issuer |
| Aug 30, 2024 | 6-K | Report of foreign issuer |